Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075163 Target Snapshot

Serine/threonine-protein kinase haspin · SINGLE PROTEIN · Homo sapiens

829Compounds
267Assays
0Approved Drugs
365.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8TF76. Use UniProt Q8TF76 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8TF76 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serine/threonine-protein kinase haspin as ChEMBL target CHEMBL1075163, mapped to UniProt Q8TF76. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serine/threonine-protein kinase haspin
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1075163
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8TF76
Serine/threonine-protein kinase haspin
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serine/threonine-protein kinase haspin is the right protein anchor across sources, using UniProt Q8TF76 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSerine/threonine-protein kinase haspin
UniProt AccessionQ8TF76
Component TypeProtein
Sequence Length798 aa

Serine/threonine-protein kinase haspin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serine/threonine-protein kinase haspin, mapped to UniProt Q8TF76. Sequence length is 798 aa.

Mapped IDQ8TF76
Review nameSerine/threonine-protein kinase haspin
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
5
Phase I
Assay Mix

Activity Type Distribution

IC50343.0
KD22.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5199572 10.72 Kd 0.019 Preclinical
CHEMBL5574055 9.81 IC50 0.155 Preclinical
CHEMBL5194339 9.38 Kd 0.42 Preclinical
CHEMBL5440655 9.26 Kd 0.55 Preclinical
CHEMBL4791276 8.8 IC50 1.6 Preclinical
CHEMBL5178368 8.7 IC50 2.0 Preclinical
CHEMBL5186093 8.52 IC50 3.0 Preclinical
CHEMBL5201780 8.52 IC50 3.0 Preclinical
CHEMBL5563528 8.52 IC50 3.0 Preclinical
CHEMBL4064608 8.4 IC50 4.0 Preclinical
Distribution

pChEMBL Value Distribution

19
5.0
27
5.5
48
6.0
54
6.5
38
7.0
22
7.5
14
8.0
8
8.5
2
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

267
Total Assays
205
Tested Compounds
3
Assay Types
Binding — 260 assays, 205 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 175 140 6.7
assay format 49 61 6.7
cell-based format 34 3 9.0
subcellular format 1 1 6.1
tissue-based format 1 0
ADME — 5 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 3 5.9
single protein format 1 0
Toxicity — 2 assays, 18 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 18 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine